Dietary supplement

GenTech Provides Year-to-Date Performance Update: 2021 Revenues on Pace for $1.3M, with 2022 Showing Potential for 800% Growth

Monday, October 25, 2021 - 2:15pm

Provisional topline revenue numbers for the nine months to September 30 show Gross Consolidated Revenues from operations currently at $745,900.

Key Points:

Provisional topline revenue numbers for the nine months to September 30 show Gross Consolidated Revenues from operations currently at $745,900.
David Lovatt, CEO of GenTech Holdings, commented, These figures show exceptional growth relative to 2020 performance data.
If you add in a full inventory for NxtBar and Nature Soothie, our 2022 revenue outlook jumps to over $3.5 million.
This press release may contain forward-looking statements, including information about management's view of GenTech, Inc.'s future expectations, plans and prospects.

National Academy of Sports Medicine® Launches New Certified Sports Nutrition Program to Help Maximize Athletic Performance

Monday, October 25, 2021 - 2:00pm

Today the National Academy of Sports Medicine (NASM) , a world leader in fitness certifications, announced the launch of its newest program, Certified Sports Nutrition Coach (NASM-CSNC) .

Key Points:

Today the National Academy of Sports Medicine (NASM) , a world leader in fitness certifications, announced the launch of its newest program, Certified Sports Nutrition Coach (NASM-CSNC) .
NASM developed the CSNC program with the industry-leading experts at the Institute of Performance Nutrition (IOPN).
The program modules include: The Performance Nutrition Profession; Metabolism and Energetics; Nutrients and Hydration; Performance and Nutrition Strategies; and Putting Science into Practice.
About IOPN: The Institute of Performance Nutrition is a UK based professional education institute, specializing in Performance Nutrition for current and aspiring sport and exercise nutritionists.

NCCN Works with Polish Health Leaders to Improve Cancer Standardization, Coordination, and Outcomes

Monday, October 25, 2021 - 2:13pm

PLYMOUTH MEETING, Pa., Oct. 25, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—today announced the publication of new NCCN Guidelines® for Cervical Cancer: Poland Edition. This is the organization's most-recent collaboration to advance global cancer care through recommendations based on the latest evidence and expert consensus. NCCN also works on regional guidelines adaptations, translations, and harmonizations with local providers across Sub-Saharan Africa, the Middle East and North Africa (MENA), the Caribbean, and other countries in Asia, Europe, and South America.

Key Points:

PLYMOUTH MEETING, Pa., Oct. 25, 2021 /PRNewswire/ --The National Comprehensive Cancer Network ( NCCN )an alliance of leading cancer centers in the United Statestoday announced the publication of new NCCN Guidelines for Cervical Cancer: Poland Edition.
The project is led by Polish oncologists and includes the Health Technology Assessment Agency, National Health Fund, Ministry of Health representatives, and Polish patient advocacy groups.
The National Comprehensive Cancer Network ( NCCN ) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education.
The NCCN Guidelines for Patients provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation .

MedStar Health Leads $5 Million CDC-Funded Project Aimed at Improving Cancer Survivorship and Reducing Patient Inequities

Monday, October 25, 2021 - 2:00pm

Over the next five years, the study will focus on breast and prostate cancer patients finishing treatment at three Washington, D.C.-based cancer clinics, using strategies to reduce health inequities and improve their outcomes.

Key Points:

Over the next five years, the study will focus on breast and prostate cancer patients finishing treatment at three Washington, D.C.-based cancer clinics, using strategies to reduce health inequities and improve their outcomes.
Researchers hope the project will eventually lead to a permanent and sustainable process for addressing social determinants of health and enhancing cancer care for minoritized communities.
"Despite improvements in cancer outcomes over time, significant disparities remain between Black and white cancer survivors," said Arem, scientific director at MedStar Health Research Institute .
In August, MedStar announced a new software integration that embeds the social needs screening tool directly into patient Electronic Health Records (EHRs).

Tremeau Expands Pipeline with Novel Non-Opioid Compound for the Treatment of Acute Pain

Monday, October 25, 2021 - 1:45pm

Once issued, the patent will provide composition of matter patent protection for Tremeaus novel deuterium-enriched etoricoxib compound, TRM-362 (d3-etoricoxib), through at least April 2041.

Key Points:

Once issued, the patent will provide composition of matter patent protection for Tremeaus novel deuterium-enriched etoricoxib compound, TRM-362 (d3-etoricoxib), through at least April 2041.
These studies suggest that TRM-362 could provide similar or greater acute pain efficacy when compared to non-enriched etoricoxib, potentially at a lower dose.
The surgical community would welcome a more potent non-opioid pain medication that does not carry the bleeding risk of traditional NSAIDs.
We will work proactively with FDA to design a product for acute pain that ensures access only for short-term use.

How Common Are Elevator & Escalator Injuries?

Monday, October 25, 2021 - 1:04pm

Elevator injuries are more common, with approximately 10,200 elevator accidents involving injuries occurring each year.

Key Points:

Elevator injuries are more common, with approximately 10,200 elevator accidents involving injuries occurring each year.
The permit, or a copy thereof, to operate a passenger elevator, freight elevator or incline elevator shall be posted conspicuously and securely in the elevator car.
A state inspector must check the condition of the elevator or escalator to determine if it is safe for passengers.
More than half of all elevator and escalator accidents in the country were connected to maintenance and repair neglect .

Specialty Enzymes & Probiotics is pleased to announce SEBtilis™ received a No Objections Letter from the FDA for its GRAS submission. GRAS stands for Generally Recognized As Safe.

Safety, Probiotic, Lipid metabolism, Research, Specialty, Disease, Bacillus subtilis, History, FDA, GRAS, Refrigeration, Food, Health Canada, Bacillus, Food and Drug Administration, Multimedia, Dietary supplement

Monday, October 25, 2021 - 1:00pm

A spore-forming, shelf-stable probiotic, SEBtilis (Bacillus subtilis), creates a protective endospore around itself that allows it to survive the journey to the gut, where it thrives.

Key Points:

A spore-forming, shelf-stable probiotic, SEBtilis (Bacillus subtilis), creates a protective endospore around itself that allows it to survive the journey to the gut, where it thrives.
It is also able to withstand manufacturing and distribution practices without refrigeration, saving manufacturer resources.
*
Studies show SEBtilis (Bacillus subtilis) promotes intestinal homeostasis, the production of antimicrobials targeting pathogenic organisms, lipid metabolism, normal oxidative stress levels, and immune health.
*
SEBtilis (Bacillus subtilis) has also received approval as a natural health product by Health Canada.

Happiness Biotech Acquires Majority Ownership in Fujian Shennong

Monday, October 25, 2021 - 1:00pm

NANPING, China, Oct. 25, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce solutions, and the sales of automobile, today announced that it and its wholly owned-subsidiary, Fujian Happiness Biotech Co., Limited ("Happiness Fujian") have signed a share transfer agreement (the "Agreement") to acquire 70% of the equity interest in Fujian Shennong Jiagu Development Co., Ltd. ("Fujian Shennong") to further strengthen the Company's industrial integration.

Key Points:

NANPING, China, Oct. 25, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce solutions, and the sales of automobile, today announced that it and its wholly owned-subsidiary, Fujian Happiness Biotech Co., Limited ("Happiness Fujian") have signed a share transfer agreement (the "Agreement") to acquire 70% of the equity interest in Fujian Shennong Jiagu Development Co., Ltd. ("Fujian Shennong") to further strengthen the Company's industrial integration.
Pursuant to the terms of the Agreement, Happiness Biotech will issue 4.2 million shares to a certain equity owner of Fujian Shennong (the "Seller") and make a cash payment of RMB48 million (approximately $7.5 million) in exchange for the 70% equity of Fujian Shennong.
"We are very glad that we have finally entered into an agreement for the acquisition of the majority equity of Fujian Shennong.
We have had a lengthy negotiation with Fujian Shennong and after the in-depth due diligence and audit of Fujian Shennong, we are very impressed with Shennong's management and achievements in its trading and supply chain business.

Social enterprise, Lucky Iron Fish, completes Series A Funding with a new investment from Danone Communities to better help address iron deficiency

Monday, October 25, 2021 - 12:50pm

The investment firmly aligns with LIFes mission to create innovations that help improve global health and well-being by tackling malnutrition especially iron deficiency.

Key Points:

The investment firmly aligns with LIFes mission to create innovations that help improve global health and well-being by tackling malnutrition especially iron deficiency.
On this investment, Anna Perinic, Business Development Nutrition Director at Danone Communities, who will also be joining the Lucky Iron Fish board of directors, said:
Im excited about this new partnership with Lucky Iron Fish, the 15th investment in the Danone Communities portfolio.
The Lucky Iron Fish is a clinically proven cooking tool that infuses meals with iron to help treat and prevent iron deficiency.
Lucky Iron Fish Enterprise (LIFe) is on a mission to improve global health by making iron deficiency a thing of the past.

Nirvana Water Sciences wins Best Technology Innovation at Global Water Drinks Awards

Science, Research, Quality of life, D3, HMB, Leadership, Technology, Golden Ticket Award for Best New Ride, Water, Dietary supplement

Monday, October 25, 2021 - 12:50pm

NEW YORK, Oct. 25, 2021 /PRNewswire/ --Nirvana Water Sciences Corp. ("Nirvana"), is pleased to have won Best Technology Innovation for its Nirvana HMB spring water at the 2021 Global Water Drinks Awards.

Key Points:

NEW YORK, Oct. 25, 2021 /PRNewswire/ --Nirvana Water Sciences Corp. ("Nirvana"), is pleased to have won Best Technology Innovation for its Nirvana HMB spring water at the 2021 Global Water Drinks Awards.
In addition to its win for innovation, Nirvana was also a finalist in the categories of Best New Water Concept, Best Marketing/Social Media Campaign, and Best New Brand, all for its innovative and unique Nirvana HMB spring water.
Organized by the international food and drink experts Zenith Global, the 7th annual Global Water Drinks Awards attracted over 165 entries with participation from every continent worldwide.
In Q1 2022 it will introduce Nirvana HMB + D3, complementing its signature Nirvana HMB spring water and adding to Nirvana's growing product line of innovative HMB infused spring water products.